-
IntroducedFeb 27, 2020
-
Passed House
-
Passed Senate
-
Signed into Law
AN ACT CONCERNING THE COST OF PRESCRIPTION DRUGS. To: (1) Cap aggregate monthly cost-sharing for prescription drugs covered under certain individual and group health insurance policies; (2) cap the cost of generic drugs in this state; (3) require the Commissioner of Consumer Protection to submit a request to the federal Secretary of Health and Human Services to implement a Canadian prescription drug reimportation program in this state and, if the secretary approves such request, implement such program in this state; (4) require pharmaceutical manufacturers to send notice to the Insurance Commissioner regarding "pay-for-delay" agreements, and require health carriers and pharmacy benefits managers to reduce the cost of brand name prescription drugs that are the subject of such agreements; (5) establish a Critical Drug Shortage Review Board; and (6) limit the circumstances in which a health carrier may remove a prescription drug from a drug formulary or list of covered drugs, or move a prescription drug to a different cost-sharing tier, during a plan year.
Last Action See all actions
House • Mar 11, 2020: Filed with Legislative Commissioners' Office
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HB 5366
Tweets
Whip Lists
Sponsors
- Insurance and Real Estate Committee
Votes
YES: 15
- Lesser M.
- Scanlon S.
- Hartley J.
- Dathan L.
- Pavalock-D'Amato C.
- Anwar S.
- Bizzarro G.
- Cassano S.
- de la Cruz J.
- Delnicki T.
- Hughes A.
- Polletta J.
- Riley E.
- Rosario C.
- Turco G.
NO: 4
- Kelly K.
- Floren L.
- O'Neill A.
- Vail K.
ABSENT: 1
- Nolan A.
Actions
- Mar 11, 2020 | House
- Filed with Legislative Commissioners' Office
- Mar 10, 2020 | House
- Joint Favorable Substitute
- Feb 28, 2020 | House
- Public Hearing 03/03
- Feb 27, 2020 | House
- Referred to Joint Committee on Insurance and Real Estate
Bill Texts
Documents